N 6 ‐methyladenosine Steers RNA Metabolism and Regulation in Cancer
Open Access
- 6 May 2021
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Cancer Communications
- Vol. 41 (7) , 538-559
Abstract
As one of the most studied ribonucleic acid (RNA) modifications in eukaryotes, N 6 ‐methyladenosine (m 6 A) has been shown to play a predominant role in controlling gene expression and influence physiological and pathological processes such as oncogenesis and tumor progression. Writer and eraser proteins, acting opposite to deposit and remove m 6 A epigenetic marks, respectively, shape the cellular m 6 A landscape, while reader proteins preferentially recognize m 6 A modifications and mediate fate decision of the methylated RNAs, including RNA synthesis, splicing, exportation, translation, and stability. Therefore, RNA metabolism in cells is greatly influenced by these three classes of m 6 A regulators. Aberrant expression of m 6 A regulators has been widely reported in various types of cancer, leading to cancer initiation, progression, and drug resistance. The close links between m 6 A and cancer shed light on the potential use of m 6 A methylation and its regulators as prognostic biomarkers and drug targets for cancer therapy. Given the notable effects of m 6 A in reversing chemoresistance and enhancing immune therapy, it is a promising target for combined therapy. Herein, we summarize the recent discoveries on m 6 A and its regulators, emphasizing their influences on RNA metabolism, their dysregulation and impacts in diverse malignancies, and discuss the clinical implications of m 6 A modification in cancer.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China
This publication has 213 references indexed in Scilit:
- Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesisJournal of Clinical Investigation, 2013
- ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse FertilityMolecular Cell, 2013
- Development of Cell-Active N6-Methyladenosine RNA Demethylase FTO InhibitorJournal of the American Chemical Society, 2012
- Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop CodonsCell, 2012
- Topology of the human and mouse m6A RNA methylomes revealed by m6A-seqNature, 2012
- Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem CellsCell, 2012
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTONature Chemical Biology, 2011
- Oxidative demethylation of 3‐methylthymine and 3‐methyluracil in single‐stranded DNA and RNA by mouse and human FTOFEBS Letters, 2008
- MicroRNA expression profiles classify human cancersNature, 2005
- Existence of methylated messenger RNA in mouse L cellsCell, 1974